首页> 外文期刊>Bone marrow transplantation >Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism.
【24h】

Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism.

机译:成功的非T细胞耗竭的非清髓性造血干细胞移植(HST)是由HLA单倍型2位错配的同胞在患有严重的再生障碍性贫血的严重输血患者中产生的,其原因是基于Fetomaternal微嵌合体。

获取原文
获取原文并翻译 | 示例
       

摘要

A 37-year-old Japanese man with systemic hemochromatosis due to multiple transfusions was referred to us for the treatment of severe aplastic anemia (SAA), from which he had been suffering for 24 years. The patient had diabetes arising from the hemochromatosis, chronic anal fissures, and a kidney abscess due to neutropenia. He was treated with a nonmyeloablative preconditioning regimen followed by non-T-cell-depleted (non-TCD) allogeneic peripheral blood stem cell transplantation (PBSCT) from his human leukocyte antigen (HLA)-haploidentical 2-loci-mismatched sibling. Prompt engraftment of granulocytes and platelets was observed, and graft-versus-host disease was easy to control. Noninherited maternal antigens in the donor were confirmed prior to PBSCT, and they were also detected in small quantities in the recipient. This report describes the first successful nonmyeloablative hematopoietic stem cell transplant in a heavily transfused SAA patient from an HLA-haploidentical 2-loci-mismatched sibling donor. The result suggests that a long-term fetomaternal microchimerism-positive sibling can be a second-line donor if an alternative HLA-identical donor is not available.
机译:一名因多次输血而患有全身性血色素沉着症的37岁日本男子被转介给我们治疗严重再生障碍性贫血(SAA),该病已困扰他24年。该患者患有因血色素沉着症,慢性肛裂和中性粒细胞减少症引起的肾脓肿引起的糖尿病。他接受了非清髓性预处理方案治疗,然后接受了来自他的人白细胞抗原(HLA)的单倍2位错配的同胞的非T细胞耗竭(non-TCD)同种异体外周血干细胞移植(PBSCT)。观察到粒细胞和血小板的迅速移植,并且移植物抗宿主病易于控制。在PBSCT之前确认了供体中未遗传的母体抗原,并且在接受者中也少量检测到了它们。这份报告描述了从HLA单倍型2位错配的同胞供者大量输血的SAA患者中首次成功的非清髓性造血干细胞移植。结果表明,如果没有替代的HLA相同的供体,则长期的胎儿母亲微嵌合体阳性兄弟姐妹可以成为二线供体。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号